The system is the first in the world to both automatically suspend insulin delivery when sensor glucose levels are predicted to approach a low limit, and then resume insulin delivery once sensor glucose levels recover. The system includes the Enhanced Enlite sensor, which continuously monitors glucose levels. The product also incorporates a new insulin pump design to provide convenient diabetes management with a simple user interface, full-color, light-adjusting screen, customizable alerts and alarms, remote bolus, and waterproofing in up to 12 feet of water for 24 hours at a time.
SmartGuard (or predictive low glucose management) technology is designed to optimize the MiniMed 640G System’s ability to better protect people with diabetes against lows throughout the day and night with multiple low-limit settings that can be tailored to individual needs.
In addition, the MiniMed 640G System exclusively uses the Bayer CONTOUR® NEXT LINK 2.4 blood glucose meter to provide highly accurate blood glucose testing, automatically transmit blood glucose results into the Bolus Wizard calculator to help ensure that patients do not have a manual entry error, and to calibrate the Enhanced Enlite sensor. This also allows patients to discreetly give a bolus of insulin remotely from the meter. The meter provides added convenience to help patients manage their diabetes effectively.
MiniMed 640G is now available in Australia. Launches in additional markets are expected over the next several months, pending local approvals.